Quality by design for biopharmaceuticals: a historical review and guide for implementation

Simple item page
dc.contributor.authorElliott, P.
dc.contributor.authorBi, J.
dc.contributor.authorZhang, H.
dc.date.issued2013
dc.description.abstractThis article reviews the history of quality-by-design (QbD), how this concept has been applied to biopharmaceuticals, and what can be expected from implementation of QbD. Although QbD may lead to better design of products and manufacturing processes, and offers the potential for reduced regulatory compliance costs, it will likely increase development costs. Process developers will require additional skills and knowledge in the ‘quality disciplines’, which are not normally part of the training of those in biopharmaceutical process development. A model for implementing QbD in biopharmaceutical manufacture is proposed. The reader will gain an understanding of how QbD principles have been applied to the development of biopharmaceuticals, as well as learning of the potential drawbacks of applying QbD tools indiscriminately. Excellent examples of QbD applied to biopharmaceuticals in the literature will be highlighted and suggested as the direction for future development in this area.
dc.description.statementofresponsibilityPhillip Elliott, Sam Billingham, Jingxiu Bi & Hu Zhang
dc.identifier.citationPharmaceutical Bioprocessing, 2013; 1(1):105-122
dc.identifier.doi10.4155/pbp.13.6
dc.identifier.issn2048-9145
dc.identifier.issn2048-9153
dc.identifier.orcidBi, J. [0000-0001-7056-8572]
dc.identifier.orcidZhang, H. [0000-0003-4178-6401]
dc.identifier.urihttp://hdl.handle.net/2440/82393
dc.language.isoen
dc.publisherFuture Science Ltd
dc.rightsFuture Science © 2013
dc.source.urihttps://doi.org/10.4155/pbp.13.6
dc.titleQuality by design for biopharmaceuticals: a historical review and guide for implementation
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Chemical Engineering publications